Chemring Group PLC has provided an update on countermeasure deliveries. The company had previously noted that achieving current full-year expectations was subject to US Department of Defense approval of certain countermeasure deliveries, representing approximately £25 million of revenue. The delay in approval was due to the quality of raw material provided by a third-party supplier, which was outside of the company's control. However, the majority of the necessary approvals have now been received, and associated deliveries can now be made. The revenue and profit associated with these deliveries can subsequently be recognized. However, there may be a delay in cash receipts from the customer, which may fall into early FY24. The outturn for the year ending 31 October 2023 remains in line with the board's and current analyst expectations. The consensus of analyst forecasts for adjusted operating profit for the year is £66.2 million. Chemring Group PLC is a FTSE-250 listed global business that specializes in the manufacture of high technology products and the provision of services to the aerospace, defense, and security markets. The company employs approximately 2,600 people worldwide and operates in niche markets with a diverse portfolio of products.